Home
VolitionRx Limited

VolitionRx Limited Market Share Analysis for November 2025

Revolutionizing early diagnosis and monitoring of life-altering diseases. Driving the future of epigenetics through nucleosome quantification.

Business and Consumer Services > Business Services

Domainvolition.com

Year Founded1998

Employees51 - 200

Annual Revenue$2M - $5M

VolitionRx Limited

VolitionRx Limited (including company regionals)

volition.com

See more website traffic and engagement information

VolitionRx Limited Revenue up to November 2025 is 2M - 5M

revenue generated by VolitionRx Limited top domains

VolitionRx Limited top domains revenue over 3 years

Revenue for VolitionRx Limited top domains

volition.com2M - 5M

See more with Sales Intelligence

Total visits to VolitionRx Limited's top domains

Understand VolitionRx Limited market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

volition.com11.4K

See more with Sales Intelligence

Avg. visit duration in VolitionRx Limited's top domains

Analyze VolitionRx Limited engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

volition.com00:00:29

See more with Sales Intelligence

Avg. pageviews on VolitionRx Limited's top domains

See how VolitionRx Limited keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

volition.com1.67

See more with Sales Intelligence

VolitionRx Limited top competitors by domain

Top similar sites in November 2025, ranked by their affinity

realtor.comCompany NameRealtorEmployees1001 - 5000HQUnited States, Texas, AustinAnnual revenue$100M - $200MTotal visits101.6MBusiness and Consumer Services > Real Estate

Top technologies used by VolitionRx Limited

These are the website technologies, by industry, used by VolitionRx Limited top domains

Advertising (43)

Google Adsense

Payment & Currencies (23)

PayPal

Conversion & Analytics (10)

Google Analytics

Marketing (6)

Google Marketing Platform

More Technologies

13

See all

News & Signals from VolitionRx Limited

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsD. Boral Capital LLC sells assets to VolitionRx Ltd.VolitionRx (NYSE:VNRX) earns buy rating from D. Boral Capital.

NewsVolitionRx Ltd partners with Werfen Ltd.VolitionRx partners with Werfen to advance diagnostic testing for antiphospholipid syndrome.

NewsVolitionRx Ltd attends event IAS 2025.At IAS 2025, the VOLITION and OPERA study data presented at IAS 2025 show patient preference and real-world use of injectable CAB + RPV LA, informing the treatment strategy of ViiV CMO Jean van Wyk.